Fecal Microbiota Transplantation for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 9, 2022

Study Completion Date

December 9, 2022

Conditions
Parkinson Disease
Interventions
OTHER

Donor FMT

Fecal microbiota transplantation through nasojejunal administration. Fecal matter will be collected prior to the start of the study from healthy donors and will be frozen at -80°C after thorough screening for infectious diseases. At the time of transplantation, samples will be thawed and administrated to the patients in the treatment group.

OTHER

Autologous FMT

Fecal microbiota transplantation through nasojejunal administration. Fecal matter will be collected prior to the start of the study from each patient and will be frozen at -80°C after thorough screening for infectious diseases. At the time of transplantation, samples will be thawed and administrated to the patients in the control group.

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

University Hospital, Ghent

OTHER

collaborator

the Flanders Institute for Biotechnology

UNKNOWN

collaborator

Research Foundation Flanders

OTHER

collaborator

Vlaamse Parkinson Liga

UNKNOWN

collaborator

Parkili

UNKNOWN

lead

University Ghent

OTHER

NCT03808389 - Fecal Microbiota Transplantation for Parkinson's Disease | Biotech Hunter | Biotech Hunter